Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06938152 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv6
  2. Primary completion date: Apr 15, 2029 to Apr 30, 2029 Publications: details revised at 12 of 12 entriesv5 Show 1 more changeShow less
    • Publications: details revised at 12 of 12 entries
  3. Primary completion date: Oct 15, 2027 to Apr 15, 2029 Completion date: Dec 31, 2027 to Dec 31, 2029 · Eligibility criteria revisedv4 Show 2 more changesShow less
    • Completion date: Dec 31, 2027 to Dec 31, 2029
    • Eligibility criteria revised

    See this version in full on ClinicalTrials.gov ↗

  4. Start date changed from estimate of Apr 20, 2025 to Apr 8, 2025v3
  5. Publications: details revised at 12 of 12 entriesv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a prospective, randomized, controlled clinical trial comparing the efficacy of a 24-month cyclic therapy regimen (6 months of Romosozumab followed by 6 months of Denosumab, repeated for two years) versus a traditional sequential treatment regimen (12 months of Romosozumab followed by 12 months of Denosumab). The goal is to determine which approach yields better therapeutic outcomes and to optimize drug strategies for osteoporosis patients.
Trial Details
NCT Number NCT06938152
Lead Sponsor National Taiwan University Hospital
Conditions Osteoporosis, Osteoporosis Postmenopausal
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov